PLEIOTROPIC EFFECTS OF PLANT STEROLS COMPARED WITH EZETIMIBE ON ATHEROSCLEROSIS BIOMARKERS IN TYPE 2 DIABETIC PATIENTS TREATED WITH STATINS

被引：2
|
作者：
Bertolami, A. [1 ]
Botelho, P. B. [2 ]
Macedo, L. F. L. [2 ]
Abdalla, D. S. P. [3 ]
Faludi, A. A. [1 ]
Galasso, M. [2 ]
Castro, I. [4 ]
机构：
[1] Dante Pazzanese Inst Cardiol, Dyslipidemia Med Sect, Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil
[4] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil
来源：
ATHEROSCLEROSIS | 2014年 / 235卷 / 02期
关键词：
D O I：
10.1016/j.atherosclerosis.2014.05.190
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0028
引用
收藏
页码：E74 / E74
页数：1
相关论文
共 50 条
  • [41] Glycooxidation in type 2 diabetic patients treated with insulin
    Dworacka, M.
    Szczawinska, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 50 - 50
  • [42] Lifestyles in Type 2 Diabetic patients treated with insulin
    Caramona, M.
    Patrao, M. C.
    Carvalheiro, M.
    Relvas, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1326 - 1326
  • [43] Protein oxidation biomarkers in plasma of type 2 diabetic patients
    Pandey, Kanti Bhooshan
    Mishra, Neetu
    Rizvi, Syed Ibrahim
    CLINICAL BIOCHEMISTRY, 2010, 43 (4-5) : 508 - 511
  • [44] Repaglinide compared to glipizide in the treatment of type 2 diabetic patients
    Dejgaard, A
    Madsbad, S
    Kilhovd, B
    Lager, I
    Mustajoki, P
    DIABETOLOGIA, 1998, 41 : A236 - A236
  • [45] Nateglinide and glibenclamide metabolic effects in naive type 2 diabetic patients treated with metformin
    Derosa, G.
    D'Angelo, A.
    Fogari, E.
    Salvadeo, S.
    Gravina, A.
    Ferrari, I.
    Cicero, A. F. G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (01) : 13 - 23
  • [46] Endothelial vasodilation effects of statins in type 2 diabetic patients - Response to van Venrooij et al.
    Sowers, JR
    DIABETES CARE, 2002, 25 (07) : 1242 - 1243
  • [47] Vascular effects of raivaroxaban compared to aspirin in type 2 diabetic patients with high cardiovascular risk
    Pistrosch, F.
    Mehling, H.
    Axthelm, C.
    Schaper, F.
    Henkel, E.
    Weigmann, I.
    Kreutzfeld, K.
    von der Osten, U.
    Koehler, C.
    Birkenfeld, A. L.
    Hanefeld, M.
    DIABETOLOGIA, 2018, 61 : S549 - S550
  • [48] Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia
    Tomassini, J. E.
    Mazzone, T.
    Goldberg, R. B.
    Guyton, J. R.
    Weinstock, R. S.
    Polis, A.
    Jensen, E.
    Tershakovec, A. M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 855 - 864
  • [49] Beneficial Effects of Hydrophilic Statins on Prevention of Adverse Cardiac Events in Diabetic Patients after Acute Myocardial Infarction as Compared to Lipophilic Statins
    Shutta, Ryu
    Nishino, Masami
    Ishiyama, Ayano
    Oonishi, Hiroyuki
    Sakatani, Akiya
    Tanaka, Akihiro
    Okamoto, Naotaka
    Kikuchi, Atsushi
    Mori, Naoki
    Masaki, Takeshi
    Lee, Yasuharu
    Yoshimura, Takahiro
    Nakamura, Daisuke
    Taniike, Masayuki
    Makino, Nobuhiko
    Kato, Hiroyasu
    Egami, Yasuyuki
    Morita, Hisaki
    Tanouchi, Jun
    Yamada, Yoshio
    Nakatani, Daisaku
    Sakata, Yasuhiko
    Komuro, Issei
    CIRCULATION, 2011, 124 (21)
  • [50] Comparative efficacy of fenofibrate/pravastatin/ezetimibe and simvastatin/ezetimibe therapies in type 2 diabetic patients with combined hyperlipidaemia and cardiovascular disease
    Farnier, M.
    Steinmetz, A.
    Csaszar, A.
    Retterstol, K.
    Dluzniewski, M.
    DIABETOLOGIA, 2010, 53
12345